Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
An unusual case of hemosiderotic fibrohistiocytic lipomatous lesion: correlation of MRI and pathologic findings.

Sarcoma

de Vreeze RS, Koops W, Haas RL, van Coevorden F.
PMID: 18584051
Sarcoma. 2008;2008:893918. doi: 10.1155/2008/893918.

The spectrum of lipomatous lesions ranges from benign to highly malignant disease. Differentiation between these lesions is important to indicate prognosis and choose the most appropriate treatment. Hemosiderotic fibrohistiocytic lipomatous lesion (HFLL) is a rare subtype of lipomatous tumor....

Cite
de Vreeze RS, Koops W, Haas RL, et al. An unusual case of hemosiderotic fibrohistiocytic lipomatous lesion: correlation of MRI and pathologic findings. Sarcoma. 2008;2008:893918doi: 10.1155/2008/893918.
de Vreeze, R. S., Koops, W., Haas, R. L., & van Coevorden, F. (2008). An unusual case of hemosiderotic fibrohistiocytic lipomatous lesion: correlation of MRI and pathologic findings. Sarcoma, 2008893918. https://doi.org/10.1155/2008/893918
de Vreeze, Ronald S A, et al. "An unusual case of hemosiderotic fibrohistiocytic lipomatous lesion: correlation of MRI and pathologic findings." Sarcoma vol. 2008 (2008): 893918. doi: https://doi.org/10.1155/2008/893918
de Vreeze RS, Koops W, Haas RL, van Coevorden F. An unusual case of hemosiderotic fibrohistiocytic lipomatous lesion: correlation of MRI and pathologic findings. Sarcoma. 2008;2008:893918. doi: 10.1155/2008/893918. PMID: 18584051; PMCID: PMC2435605.
Copy Download .nbib Format: NLM
Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands.

Sarcoma

van Broekhoven DLM, Verschoor AJ, van Dalen T, Grünhagen DJ, den Bakker MA, Gelderblom H, Bovee JVMG, Haas RLM, Bonenkamp HJ, van Coevorden F, Ten Oever D, van der Graaf WTA, Flucke UE, Pras E, Reyners AKL, Westermann AM, Oldenburger F, Verhoef C, Steeghs N.
PMID: 30034268
Sarcoma. 2018 Jun 21;2018:5982575. doi: 10.1155/2018/5982575. eCollection 2018.

INTRODUCTION: Nonsurgical management of patients with desmoid-type fibromatosis (DF) is increasing. This study tries to provide insight on type, usage, and outcome of first-line nonsurgical management strategies.PATIENTS AND METHODS: From the Dutch Pathology Registry (PALGA), patients with extra-abdominal or...

Cite
van Broekhoven DLM, Verschoor AJ, van Dalen T, et al. Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma. 2018;2018:5982575doi: 10.1155/2018/5982575.
van Broekhoven, D. L. M., Verschoor, A. J., van Dalen, T., Grünhagen, D. J., den Bakker, M. A., Gelderblom, H., Bovee, J. V. M. G., Haas, R. L. M., Bonenkamp, H. J., van Coevorden, F., Ten Oever, D., van der Graaf, W. T. A., Flucke, U. E., Pras, E., Reyners, A. K. L., Westermann, A. M., Oldenburger, F., Verhoef, C., & Steeghs, N. (2018). Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma, 20185982575. https://doi.org/10.1155/2018/5982575
van Broekhoven, Danique L M, et al. "Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands." Sarcoma vol. 2018 (2018): 5982575. doi: https://doi.org/10.1155/2018/5982575
van Broekhoven DLM, Verschoor AJ, van Dalen T, Grünhagen DJ, den Bakker MA, Gelderblom H, Bovee JVMG, Haas RLM, Bonenkamp HJ, van Coevorden F, Ten Oever D, van der Graaf WTA, Flucke UE, Pras E, Reyners AKL, Westermann AM, Oldenburger F, Verhoef C, Steeghs N. Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma. 2018 Jun 21;2018:5982575. doi: 10.1155/2018/5982575. eCollection 2018. PMID: 30034268; PMCID: PMC6032644.
Copy Download .nbib Format: NLM
Adult pelvic sarcomas: a heterogeneous collection of sarcomas?.

Sarcoma

Keyzer-Dekker CM, Houtkamp RG, Peterse JL, Van Coevorden F.
PMID: 18521389
Sarcoma. 2004;8(1):19-24. doi: 10.1080/13577140410001679211.

Introduction. Adult pelvic soft tissue sarcomas are a rare group of heterogeneous malignancies. These sarcomas differ from extremity and trunk soft tissue sarcomas in presentation, characteristics and response to treatment.Methods. A retrospective analysis of patient and tumor characteristics, treatment...

Cite
Keyzer-Dekker CM, Houtkamp RG, Peterse JL, et al. Adult pelvic sarcomas: a heterogeneous collection of sarcomas?. Sarcoma. 2004;8(1):19-24doi: 10.1080/13577140410001679211.
Keyzer-Dekker, C. M., Houtkamp, R. G., Peterse, J. L., & Van Coevorden, F. (2004). Adult pelvic sarcomas: a heterogeneous collection of sarcomas?. Sarcoma, 8(1), 19-24. https://doi.org/10.1080/13577140410001679211
Keyzer-Dekker, Claudia M G, et al. "Adult pelvic sarcomas: a heterogeneous collection of sarcomas?." Sarcoma vol. 8,1 (2004): 19-24. doi: https://doi.org/10.1080/13577140410001679211
Keyzer-Dekker CM, Houtkamp RG, Peterse JL, Van Coevorden F. Adult pelvic sarcomas: a heterogeneous collection of sarcomas?. Sarcoma. 2004;8(1):19-24. doi: 10.1080/13577140410001679211. PMID: 18521389; PMCID: PMC2395600.
Copy Download .nbib Format: NLM
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.

JAMA oncology

Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL.
PMID: 33180100
JAMA Oncol. 2021 Jan 01;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21.

IMPORTANCE: Currently, preoperative radiotherapy for all soft-tissue sarcomas is identical at a 50-Gy dose level, which can be associated with morbidity, particularly wound complications. The observed clinical radiosensitivity of the myxoid liposarcoma subtype might offer the possibility to reduce...

Cite
Lansu J, Bovée JVMG, Braam P, et al. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA Oncol. 2021;7(1):e205865doi: 10.1001/jamaoncol.2020.5865.
Lansu, J., Bovée, J. V. M. G., Braam, P., van Boven, H., Flucke, U., Bonenkamp, J. J., Miah, A. B., Zaidi, S. H., Thway, K., Bruland, �. �. S., Baldini, E. H., Jebsen, N. L., Scholten, A. N., van den Ende, P. L. A., Krol, A. D. G., Ubbels, J. F., van der Hage, J. A., van Werkhoven, E., Klomp, H. M., van der Graaf, W. T. A., van Coevorden, F., Schrage, Y., van Houdt, W. J., & Haas, R. L. (2021). Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA oncology, 7(1), e205865. https://doi.org/10.1001/jamaoncol.2020.5865
Lansu, Jules, et al. "Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial." JAMA oncology vol. 7,1 (2021): e205865. doi: https://doi.org/10.1001/jamaoncol.2020.5865
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL. Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA Oncol. 2021 Jan 01;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21. PMID: 33180100; PMCID: PMC7662477.
Copy Download .nbib Format: NLM
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY.
PMID: 30188977
Ann Oncol. 2018 Oct 01;29:iv267. doi: 10.1093/annonc/mdy320.

No abstract available.

Cite
Casali PG, Abecassis N, Aro HT, et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv267doi: 10.1093/annonc/mdy320.
Casali, P. G., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W. T. A., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J. Y. (2018). Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 29iv267. https://doi.org/10.1093/annonc/mdy320
Casali, P G, et al. "Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up." Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 (2018): iv267. doi: https://doi.org/10.1093/annonc/mdy320
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 01;29:iv267. doi: 10.1093/annonc/mdy320. PMID: 30188977.
Copy Download .nbib Format: NLM
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms.

European journal of cancer (Oxford, England : 1990)

Callegaro D, Barretta F, Swallow CJ, Strauss DC, Bonvalot S, Honorè C, Stoeckle E, van Coevorden F, Haas R, Rutkowski P, Schrage Y, Fairweather M, Conti L, Vassos N, Gladdy RA, Ng D, van Houdt WJ, Miceli R, Raut CP, Gronchi A.
PMID: 34555648
Eur J Cancer. 2021 Nov;157:291-300. doi: 10.1016/j.ejca.2021.08.008. Epub 2021 Sep 20.

PURPOSE: The aim of this study was to create and validate dynamic nomograms to predict overall survival (OS) and disease-free survival (DFS) at different time points during follow-up in patients who had undergone resection of primary retroperitoneal sarcoma (RPS).METHODS:...

Cite
Callegaro D, Barretta F, Swallow CJ, et al. Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms. Eur J Cancer. 2021;157:291-300doi: 10.1016/j.ejca.2021.08.008.
Callegaro, D., Barretta, F., Swallow, C. J., Strauss, D. C., Bonvalot, S., Honorè, C., Stoeckle, E., van Coevorden, F., Haas, R., Rutkowski, P., Schrage, Y., Fairweather, M., Conti, L., Vassos, N., Gladdy, R. A., Ng, D., van Houdt, W. J., Miceli, R., Raut, C. P., & Gronchi, A. (2021). Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms. European journal of cancer (Oxford, England : 1990), 157291-300. https://doi.org/10.1016/j.ejca.2021.08.008
Callegaro, Dario, et al. "Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms." European journal of cancer (Oxford, England : 1990) vol. 157 (2021): 291-300. doi: https://doi.org/10.1016/j.ejca.2021.08.008
Callegaro D, Barretta F, Swallow CJ, Strauss DC, Bonvalot S, Honorè C, Stoeckle E, van Coevorden F, Haas R, Rutkowski P, Schrage Y, Fairweather M, Conti L, Vassos N, Gladdy RA, Ng D, van Houdt WJ, Miceli R, Raut CP, Gronchi A. Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms. Eur J Cancer. 2021 Nov;157:291-300. doi: 10.1016/j.ejca.2021.08.008. Epub 2021 Sep 20. PMID: 34555648.
Copy Download .nbib Format: NLM
A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma.

Acta oncologica (Stockholm, Sweden)

van Meekeren M, Bovee JVMG, van Coevorden F, van Houdt W, Schrage Y, Koenen AM, Miah AB, Zaidi S, Hayes AJ, Thway K, Krol S, Fiocco M, Gelderblom H, Steeghs N, Haas RL.
PMID: 34554030
Acta Oncol. 2021 Dec;60(12):1557-1564. doi: 10.1080/0284186X.2021.1971294. Epub 2021 Sep 23.

PURPOSE: A prior phase I study showed that the neo-adjuvant combination of pazopanib and radiotherapy was well tolerated, and induced promising pathological responses in soft-tissue sarcoma patients. Results of the subsequent prospective, multicenter phase II, PASART-2 trial are presented...

Cite
van Meekeren M, Bovee JVMG, van Coevorden F, et al. A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma. Acta Oncol. 2021;60(12):1557-1564doi: 10.1080/0284186X.2021.1971294.
van Meekeren, M., Bovee, J. V. M. G., van Coevorden, F., van Houdt, W., Schrage, Y., Koenen, A. M., Miah, A. B., Zaidi, S., Hayes, A. J., Thway, K., Krol, S., Fiocco, M., Gelderblom, H., Steeghs, N., & Haas, R. L. (2021). A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma. Acta oncologica (Stockholm, Sweden), 60(12), 1557-1564. https://doi.org/10.1080/0284186X.2021.1971294
van Meekeren, Milan, et al. "A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma." Acta oncologica (Stockholm, Sweden) vol. 60,12 (2021): 1557-1564. doi: https://doi.org/10.1080/0284186X.2021.1971294
van Meekeren M, Bovee JVMG, van Coevorden F, van Houdt W, Schrage Y, Koenen AM, Miah AB, Zaidi S, Hayes AJ, Thway K, Krol S, Fiocco M, Gelderblom H, Steeghs N, Haas RL. A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma. Acta Oncol. 2021 Dec;60(12):1557-1564. doi: 10.1080/0284186X.2021.1971294. Epub 2021 Sep 23. PMID: 34554030.
Copy Download .nbib Format: NLM
Author's reply.

Ophthalmology

Van Coevorden RE, Mills RP, Wang L, Stanford DC.
PMID: 10919880
Ophthalmology. 2000 Aug;107(8):1438-9. doi: 10.1016/s0161-6420(00)00291-8.

No abstract available.

Cite
Van Coevorden RE, Mills RP, Wang L, et al. Author's reply. Ophthalmology. 2000;107(8):1438-9doi: 10.1016/s0161-6420(00)00291-8.
Van Coevorden RE, Mills, R. P., Wang, L., & Stanford, D. C. (2000). Author's reply. Ophthalmology, 107(8), 1438-9. https://doi.org/10.1016/s0161-6420(00)00291-8
Van Coevorden RE, et al. "Author's reply." Ophthalmology vol. 107,8 (2000): 1438-9. doi: https://doi.org/10.1016/s0161-6420(00)00291-8
Van Coevorden RE, Mills RP, Wang L, Stanford DC. Author's reply. Ophthalmology. 2000 Aug;107(8):1438-9. doi: 10.1016/s0161-6420(00)00291-8. PMID: 10919880.
Copy Download .nbib Format: NLM
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY.
PMID: 30285214
Ann Oncol. 2018 Oct 01;29:iv268-iv269. doi: 10.1093/annonc/mdy321.

No abstract available.

Cite
Casali PG, Abecassis N, Aro HT, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv268-iv269doi: 10.1093/annonc/mdy321.
Casali, P. G., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W. T. A., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J. Y. (2018). Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 29iv268-iv269. https://doi.org/10.1093/annonc/mdy321
Casali, P G, et al. "Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up." Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 (2018): iv268-iv269. doi: https://doi.org/10.1093/annonc/mdy321
Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 01;29:iv268-iv269. doi: 10.1093/annonc/mdy321. PMID: 30285214.
Copy Download .nbib Format: NLM
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation.

World journal of surgical oncology

Meij V, Zuetenhorst JM, van Hillegersberg R, Kröger R, Prevoo W, van Coevorden F, Taal BG.
PMID: 16293186
World J Surg Oncol. 2005 Nov 17;3:75. doi: 10.1186/1477-7819-3-75.

BACKGROUND: Hepatic metastases of carcinoid tumors cause incapacitating symptoms, but are usually diffuse and therefore unresectable. In this article we evaluate our experiences with local treatment techniques in the management of carcinoid patients with hepatic metastases and failing systemic...

Cite
Meij V, Zuetenhorst JM, van Hillegersberg R, et al. Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol. 2005;3:75doi: 10.1186/1477-7819-3-75.
Meij, V., Zuetenhorst, J. M., van Hillegersberg, R., Kröger, R., Prevoo, W., van Coevorden, F., & Taal, B. G. (2005). Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World journal of surgical oncology, 375. https://doi.org/10.1186/1477-7819-3-75
Meij, Vincent, et al. "Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation." World journal of surgical oncology vol. 3 (2005): 75. doi: https://doi.org/10.1186/1477-7819-3-75
Meij V, Zuetenhorst JM, van Hillegersberg R, Kröger R, Prevoo W, van Coevorden F, Taal BG. Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol. 2005 Nov 17;3:75. doi: 10.1186/1477-7819-3-75. PMID: 16293186; PMCID: PMC1325231.
Copy Download .nbib Format: NLM
Author's reply.

Ophthalmology

Van Coevorden RE, Chen YY, Barnebey HS, Mills RP.
PMID: 10919882
Ophthalmology. 2000 Aug;107(8):1439-40. doi: 10.1016/s0161-6420(00)00135-4.

No abstract available.

Cite
Van Coevorden RE, Chen YY, Barnebey HS, et al. Author's reply. Ophthalmology. 2000;107(8):1439-40doi: 10.1016/s0161-6420(00)00135-4.
Van Coevorden RE, Chen, Y. Y., Barnebey, H. S., & Mills, R. P. (2000). Author's reply. Ophthalmology, 107(8), 1439-40. https://doi.org/10.1016/s0161-6420(00)00135-4
Van Coevorden RE, et al. "Author's reply." Ophthalmology vol. 107,8 (2000): 1439-40. doi: https://doi.org/10.1016/s0161-6420(00)00135-4
Van Coevorden RE, Chen YY, Barnebey HS, Mills RP. Author's reply. Ophthalmology. 2000 Aug;107(8):1439-40. doi: 10.1016/s0161-6420(00)00135-4. PMID: 10919882.
Copy Download .nbib Format: NLM
A single digital droplet PCR assay to detect multiple .

Oncotarget

Boonstra PA, Ter Elst A, Tibbesma M, Bosman LJ, Mathijssen R, Atrafi F, van Coevorden F, Steeghs N, Farag S, Gelderblom H, van der Graaf WTA, Desar IME, Maier J, Overbosch J, Suurmeijer AJH, Gietema J, Schuuring E, Reyners AKL.
PMID: 29568401
Oncotarget. 2018 Feb 14;9(17):13870-13883. doi: 10.18632/oncotarget.24493. eCollection 2018 Mar 02.

BACKGROUND: Gastrointestinal stromal tumors (GISTs) are characterized by oncogenic METHODS: A ddPCR assay was designed using two probes that cover both hotspots. Available archival FFPE tumor tissue from 27 consecutive patients with known KIT exon 11 mutations and 9...

Cite
Boonstra PA, Ter Elst A, Tibbesma M, et al. A single digital droplet PCR assay to detect multiple . Oncotarget. 2018;9(17):13870-13883doi: 10.18632/oncotarget.24493.
Boonstra, P. A., Ter Elst, A., Tibbesma, M., Bosman, L. J., Mathijssen, R., Atrafi, F., van Coevorden, F., Steeghs, N., Farag, S., Gelderblom, H., van der Graaf, W. T. A., Desar, I. M. E., Maier, J., Overbosch, J., Suurmeijer, A. J. H., Gietema, J., Schuuring, E., & Reyners, A. K. L. (2018). A single digital droplet PCR assay to detect multiple . Oncotarget, 9(17), 13870-13883. https://doi.org/10.18632/oncotarget.24493
Boonstra, Pieter A, et al. "A single digital droplet PCR assay to detect multiple ." Oncotarget vol. 9,17 (2018): 13870-13883. doi: https://doi.org/10.18632/oncotarget.24493
Boonstra PA, Ter Elst A, Tibbesma M, Bosman LJ, Mathijssen R, Atrafi F, van Coevorden F, Steeghs N, Farag S, Gelderblom H, van der Graaf WTA, Desar IME, Maier J, Overbosch J, Suurmeijer AJH, Gietema J, Schuuring E, Reyners AKL. A single digital droplet PCR assay to detect multiple . Oncotarget. 2018 Feb 14;9(17):13870-13883. doi: 10.18632/oncotarget.24493. eCollection 2018 Mar 02. PMID: 29568401; PMCID: PMC5862622.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries